Cargando…

Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020)

The threat from antimicrobial resistance (AMR) continues to grow. Japan’s National Action Plan on Antimicrobial Resistance, which was formulated in 2016 and targets six areas, has already had a major impact on the countermeasures implemented against AMR. Particular advances have been made in AMR-rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yoshiaki, Fujitomo, Yumiko, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614776/
https://www.ncbi.nlm.nih.gov/pubmed/34827231
http://dx.doi.org/10.3390/antibiotics10111293
_version_ 1784603942845415424
author Gu, Yoshiaki
Fujitomo, Yumiko
Ohmagari, Norio
author_facet Gu, Yoshiaki
Fujitomo, Yumiko
Ohmagari, Norio
author_sort Gu, Yoshiaki
collection PubMed
description The threat from antimicrobial resistance (AMR) continues to grow. Japan’s National Action Plan on Antimicrobial Resistance, which was formulated in 2016 and targets six areas, has already had a major impact on the countermeasures implemented against AMR. Particular advances have been made in AMR-related surveillance, and we now know the situation regarding antimicrobial use and antimicrobial-resistant bacteria in the country. Educational and awareness-raising activities for medical professionals and the general public have been actively implemented and seem to have contributed to a gradual move toward an appropriate use of antimicrobials. However, there is still insufficient understanding of the issue among the general public. Determining how to use surveillance results and implementing further awareness-raising activities are crucial to address this. Tasks for the future include both raising awareness and the promotion of AMR research and development and international cooperation. The government’s next Action Plan, which will detail future countermeasures against AMR based on the outcomes of and tasks identified in the current Action Plan, has been delayed due to the COVID-19 pandemic and is urgently awaited.
format Online
Article
Text
id pubmed-8614776
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86147762021-11-26 Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020) Gu, Yoshiaki Fujitomo, Yumiko Ohmagari, Norio Antibiotics (Basel) Review The threat from antimicrobial resistance (AMR) continues to grow. Japan’s National Action Plan on Antimicrobial Resistance, which was formulated in 2016 and targets six areas, has already had a major impact on the countermeasures implemented against AMR. Particular advances have been made in AMR-related surveillance, and we now know the situation regarding antimicrobial use and antimicrobial-resistant bacteria in the country. Educational and awareness-raising activities for medical professionals and the general public have been actively implemented and seem to have contributed to a gradual move toward an appropriate use of antimicrobials. However, there is still insufficient understanding of the issue among the general public. Determining how to use surveillance results and implementing further awareness-raising activities are crucial to address this. Tasks for the future include both raising awareness and the promotion of AMR research and development and international cooperation. The government’s next Action Plan, which will detail future countermeasures against AMR based on the outcomes of and tasks identified in the current Action Plan, has been delayed due to the COVID-19 pandemic and is urgently awaited. MDPI 2021-10-22 /pmc/articles/PMC8614776/ /pubmed/34827231 http://dx.doi.org/10.3390/antibiotics10111293 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gu, Yoshiaki
Fujitomo, Yumiko
Ohmagari, Norio
Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020)
title Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020)
title_full Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020)
title_fullStr Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020)
title_full_unstemmed Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020)
title_short Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020)
title_sort outcomes and future prospect of japan’s national action plan on antimicrobial resistance (2016–2020)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614776/
https://www.ncbi.nlm.nih.gov/pubmed/34827231
http://dx.doi.org/10.3390/antibiotics10111293
work_keys_str_mv AT guyoshiaki outcomesandfutureprospectofjapansnationalactionplanonantimicrobialresistance20162020
AT fujitomoyumiko outcomesandfutureprospectofjapansnationalactionplanonantimicrobialresistance20162020
AT ohmagarinorio outcomesandfutureprospectofjapansnationalactionplanonantimicrobialresistance20162020